This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
foafhttp://xmlns.com/foaf/0.1/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08984/identifier/wikipedia/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08984/identifier/kegg-drug/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08984/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://www.drugs.com/international/
n15http://linked.opendata.cz/resource/atc/
n14http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB08984
rdf:type
n3:Drug
n3:description
Etofenamate is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of joint and muscular pain.
n3:group
approved
owl:sameAs
n7:DB08984
dcterms:title
Etofenamate
adms:identifier
n9:Etofenamate n10:DB08984 n11:D04102
n3:synonym
WHR-5020 BAY-D-1107 SID11112716 Etofenamate SID144204169 TVX-485
n3:synthesisReference
U.S. Patent 3,692,818.
foaf:page
n13:etofenamate.html
n3:IUPAC-Name
n4:271B620D-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6213-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6212-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B620F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6210-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6211-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B620B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6209-363D-11E5-9242-09173F13E4C5 n4:271B620C-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B620A-363D-11E5-9242-09173F13E4C5
n14:hasATCCode
n15:M02AA06
n3:H-Bond-Acceptor-Count
n4:271B6219-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B621A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B6214-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6215-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6217-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6216-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6218-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
30544-47-9
n3:Bioavailability
n4:271B621F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6221-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6222-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B621E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B621D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6220-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B620E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B621B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B621C-363D-11E5-9242-09173F13E4C5